Join the 'Crofelemer' group to help and get support from people like you.
Posted 7 Oct 2014 by Drugs.com
TUESDAY, Oct. 7, 2014 – Thinking about taking a drive after popping some over-the-counter medications? Better check the label first, warn experts at the U.S. Food and Drug Administration. The agency cautions that some common nonprescription medicines can impair your ability to drive and operate other vehicles and machinery safely. Some of the most common of these drugs include certain types of nonprescription antihistamines, anti-diarrheals, and anti-nausea medications, according to the FDA. "You can feel the effects some over-the-counter medicines can have on your driving for a short time after you take them, or their effects can last for several hours," Dr. Ali Mohamadi, a medical officer at the FDA, said in an agency news release. "In some cases, a medicine can cause significant 'hangover-like' effects and affect your driving even the next day." And if you haven't had enough ... Read more
Related support groups: Benadryl, Hydroxyzine, Zyrtec, Promethazine, Claritin, Loratadine, Allegra, Diphenhydramine, Phenergan, Cetirizine, Vistaril, Meclizine, Cyproheptadine, Atarax, Fexofenadine, Imodium, Dramamine, Periactin, Acidophilus, Chlorpheniramine
Posted 2 Jan 2013 by Drugs.com
WEDNESDAY, Jan. 2 – The first medication to treat diarrhea in people with HIV/AIDS who take antiretroviral drugs has been approved by the U.S. Food and Drug Administration. Fulyzaq (crofelemer) is sanctioned for people whose diarrhea is not caused by an infection or gastrointestinal disorder but by the antiretroviral drugs used to combat HIV/AIDS, the FDA said in a news release. The drug is derived from the red sap of the Croton lechleri plant. Fulyzaq's safety and effectiveness were evaluated in a clinical study involving 374 people who were HIV-positive, on stable drug therapy and who had had diarrhea for one month or longer. About 17.6 percent of people who took Fulyzaq had a positive "clinical response," compared with a positive response among 8 percent of people who took a placebo. All participants in the study were tested to confirm that their symptoms were not caused by an ... Read more